
**Capital One (COF) is strategically targeting the lucrative premium credit card market, which could drive higher fee income from affluent customers. **GoodRx (GDRX) is positioned to benefit from high prescription drug costs, with seasonal marketing for cold and flu season potentially boosting near-term user growth. **Charles Schwab (SCHW) is focusing on attracting high-value investors by offering human guidance and educational resources, aiming for long-term client loyalty. These companies are executing clear strategies to capture valuable market segments in finance and healthcare. Investors should view these initiatives as positive indicators for potential long-term growth.

By The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, five days a week, ready by 6 a.m. Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. Listen to this podcast in New York Times Audio, our new iOS app for news subscribers. Download now at nytimes.com/audioapp